Published on: Jun 01, 2015 at OncologyNurseAdvisor

Pembrolizumab Active in Advanced Gastric Cancer

By : OncologyNurseAdvisor

The anti–PD-1 monoclonal antibody, pembrolizumab (MK-3475), demonstrated promising antitumor activity in advanced gastric cancer, results from the KEYNOTE-012 study presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting have found.

Read More
SHARE